Literature DB >> 26362720

Influence of dual-task on sit-to-stand-to-sit postural control in Parkinson's disease.

Ângela Fernandes1, Andreia S P Sousa2, Joana Couras3, Nuno Rocha4, João Manuel R S Tavares5.   

Abstract

Postural control deficits are the most disabling aspects of Parkinson's disease (PD), resulting in decreased mobility and functional independence. The aim of this study was to assess the postural control stability, revealed by variables based on the centre of pressure (CoP), in individuals with PD while performing a sit-to-stand-to-sit sequence under single- and dual-task conditions. An observational, analytical and cross-sectional study was performed. The sample consisted of 9 individuals with PD and 9 healthy controls. A force platform was used to measure the CoP displacement and velocity during the sit-to-stand-to-sit sequence. The results were statistically analysed. Individuals with PD required greater durations for the sit-to-stand-to-sit sequence than the controls (p < 0.05). The anteroposterior and mediolateral CoP displacement were higher in the individuals with PD (p < 0.05). However, only the anteroposterior CoP velocity in the stand-to-sit phase (p = 0.006) was lower in the same individuals. Comparing the single- and dual-task conditions in both groups, the duration, the anteroposterior CoP displacement and velocity were higher in the dual-task condition (p < 0.05). The individuals with PD presented reduced postural control stability during the sit-to-stand-to-sit sequence, especially when under the dual-task condition. These individuals have deficits not only in motor performance, but also in cognitive performance when performing the sit-to-stand-to-sit sequence in their daily life tasks. Moreover, both deficits tend to be intensified when two tasks are performed simultaneously.
Copyright © 2015 IPEM. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Dual-task; Parkinson's; Postural control; Sit-to-stand-to-sit

Mesh:

Year:  2015        PMID: 26362720     DOI: 10.1016/j.medengphy.2015.08.011

Source DB:  PubMed          Journal:  Med Eng Phys        ISSN: 1350-4533            Impact factor:   2.242


  6 in total

1.  Dopaminergic and non-dopaminergic gait components assessed by instrumented timed up and go test in Parkinson's disease.

Authors:  Valeria Dibilio; Alessandra Nicoletti; Giovanni Mostile; Simona Toscano; Antonina Luca; Loredana Raciti; Giorgia Sciacca; Rosario Vasta; Calogero Edoardo Cicero; Donatella Contrafatto; Mario Zappia
Journal:  J Neural Transm (Vienna)       Date:  2017-10-10       Impact factor: 3.575

2.  The Use of Cognitive Cues for Anticipatory Strategies in a Dynamic Postural Control Task - Validation of a Novel Approach to Dual-Task Testing.

Authors:  Uffe Laessoe; Bo Grarup; Jette Bangshaab
Journal:  PLoS One       Date:  2016-08-03       Impact factor: 3.240

3.  Is virtual reality beneficial for dual-task gait training in patients with Parkinson's disease? A systematic review.

Authors:  Fernanda Freitag; Sonia Maria Dozzi Brucki; Alessandra Ferreira Barbosa; Janini Chen; Carolina de Oliveira Souza; Débora Francato Valente; Hsin Fen Chien; Cynthia Bedeschi; Mariana Callil Voos
Journal:  Dement Neuropsychol       Date:  2019 Jul-Sep

4.  Visual Perturbation Suggests Increased Effort to Maintain Balance in Early Stages of Parkinson's to be an Effect of Age Rather Than Disease.

Authors:  Justus Student; David Engel; Lars Timmermann; Frank Bremmer; Josefine Waldthaler
Journal:  Front Hum Neurosci       Date:  2022-03-02       Impact factor: 3.169

5.  Comparison of the Lower Extremity Kinematics and Center of Mass Variations in Sit-to-Stand and Stand-to-Sit Movements of Older Fallers and Nonfallers.

Authors:  Yi-Ting Lin; Heng-Ju Lee
Journal:  Arch Rehabil Res Clin Transl       Date:  2022-01-25

6.  Remote smartphone gait monitoring and fall prediction in Parkinson's disease during the COVID-19 lockdown.

Authors:  Massimo Marano; Francesco Motolese; Mariagrazia Rossi; Alessandro Magliozzi; Ziv Yekutieli; Vincenzo Di Lazzaro
Journal:  Neurol Sci       Date:  2021-05-27       Impact factor: 3.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.